Table 2.
Determinants of changes in hematologic parameters during follow-up, based on mixed linear regression models
| Variable | Hemoglobin (g/dl) | Mean corpuscular | Mean corpuscular |
| volume (fl) | hemoglobin (pg) | ||
| Intercept | 9.4 (8.4 to 10.5) | 83.6 (78.7 to 88.6) | 26.9 (25.2 to 28.5) |
| Men vs. women | 0.1 (−0.2 to 0.5) | −1.3 (−2.9 to 0.3) | −0.2 (−0.7 to 0.4) |
| Age (per 10 years) | 0.07 (−0.04 to 0.2) | 0.9 (0.4 to 1.5) | 0.3 (0.2 to 0.5) |
| Duration in dialysis (per 10 months) | 0.3 (0.2 to 0.4) | −0.4 (−0.9 to 0.1) | −0.2 (−2.5 to 1.4) |
| No diabetes vs. diabetes | −0.01 (−0.4 to 0.4) | 2.4 (0.6 to 4.2) | 0.8 (0.2 to 1.5) |
| No HIV vs. HIV infection | 0.04 (−0.6 to 0.7) | −.3 (−3.3 to 2.8) | −.1 (−1.6 to 0.9) |
| No iron vs. iron therapy | −0.5 (−0.9 to −0.1) | −1.7 (−3.5 to 0.2) | −0.4 (−1.1 to 0.2) |
| No EPO vs. EPO therapy | −1.1 (−1.6 to −0.6) | −2.6 (−4.9 to −0.4) | −0.9 (−1.6 to −0.1) |
| Blood transfusion (per pint) | −0.7 (−0.9 to −0.6) | −0.1 (−0.7 to 0.5) | −0.1 (−0.2 to 0.1) |
EPO - Erythropoietin; HIV - Human Immunodeficiency Virus.